Sentence examples for context of phase from inspiring English sources

The study was performed in the context of Phase 2 of the DMIP project organized by the Hydrology Lab of the NWS.

Furthermore, 1-bit quantization is considered in the context of phase quantization [17] and a related concept named overdemodulation [18], where the received signal is down-converted with more than two carrier phases, different to 90 degrees.

Thus, in this work the general aspects of phase and viscosity behaviour linked to the type of asymmetry found in refrigerant lubricant mixtures are discussed in the context of phase behaviour phenomenology.

The context of Phase 2 and the issue to be tackled in this phase are briefly described; since this phase has been carried out only at a preliminary level (mainly after the end of the project), the results obtained are not reported here in detail but are only briefly commented on.

This better readability and presentation may be due to the particular context of phase I and II protocols, in which the evaluation of drug risks is often the main aim of the study and which often include children who have experienced treatment failure.

A variety of chemotherapeutic agents have been investigated in this setting mainly in the context of phase II trials.

In this work, we analyze the outcomes of the numerical experiments, which are based on three different anisotropy formulations within the context of phase-field modeling.

A full picture of the lipophilic process of the chemicals in the various fluids should be discussed in the context of both phase I and phase II metabolic phases.

Patients with KRAS exon 2 (codons 12 + 13 -wt CRC who had progressed on their previous anti-EGFR-based therapy (cetuximab or panitumumab) and subsequently received at least two doses of an anti-EGFR monoclonal antibody in the context of a phase I or phase I/II clinical trial at MD Anderson Cancer Center were eligible for analysis on or before 2/27/2013 -wt

Although this study was not designed to assess the potential relationships between the efficacy of imatinib and pharmacokinetics parameters, this important question is being addressed by ongoing population PK/PD modelling analyses within the context of ongoing phase II and phase III studies.

Where the toxicity of an investigational treatment is well known, or thought to be modest in the context of the phase II decision-making process, the primary phase II trial outcome measure will usually be antitumour activity, with toxicity among the secondary outcome measures.